Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.95 USD | +1.04% | +14.71% | -35.22% |
15/05 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
14/05 | Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.22% | 3.71Cr | |
-2.78% | 9.04TCr | |
+3.95% | 4.14TCr | |
-10.51% | 3.36TCr | |
+60.58% | 2.57TCr | |
-20.09% | 1.47TCr | |
-8.92% | 1.28TCr | |
-11.46% | 1.17TCr | |
-43.05% | 1.14TCr | |
+5.17% | 879.22Cr |
- Stock Market
- Equities
- FBIO Stock
- News Fortress Biotech, Inc.
- Fortress Biotech : B. Riley Lowers Fortress Biotech's PT to $8 from $9, Says Incremental Pipeline Updates Suggest Heightened Focus on Next-Gen Therapies; Keeps Buy Rating